GNIIF (GNI Group) PEG Ratio: N/A (As of Jul. 01, 2026)


GNIIF GNI Group Ltd GNIIF
82 GF Score
Price $15.50
GF Value $17.11
! 5 Warning Signs
View Full Analysis

What is GNI Group PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, GNI Group's PE Ratio without NRI is 0.00. GNI Group's 5-Year EBITDA growth rate is 0.00%. Therefore, GNI Group's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for GNI Group's PEG Ratio or its related term are showing as below:


During the past 13 years, GNI Group's highest PEG Ratio was 142.70. The lowest was 0.27. And the median was 1.26.


GNIIF's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.96
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


GNI Group  (OTCPK:GNIIF) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


GNI Group PEG Ratio Related Terms


GNI Group PEG Ratio Historical Data

* Premium members only.

The historical data trend for GNI Group's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GNI Group PEG Ratio Chart

GNI Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 5.75 0.54 4.03 0.00

GNI Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GNIIF vs VRTX, REGN, ALNY: PEG Ratio Comparison

For the Biotechnology subindustry, GNI Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GNI Group PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's PEG Ratio distribution charts can be found below:

* The bar in red indicates where GNI Group's PEG Ratio falls into.


GNIIF
82GF Score
GNI Group Ltd GNIIF
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GNI Group PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

GNI Group's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is GNI Group (GNIIF) Overvalued in 2026?

Based on GuruFocus' analysis, GNI Group stock appears to be undervalued. The current stock price of $15.50 is trading 9.4% below its estimated GF Value™ of $17.11.

Key valuation signals for GNIIF:

  • PEG Ratio: N/A
  • GF Value™: $17.11 vs. price of $15.50 (9.4% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the GNIIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GNI Group Business Description

Other Exchanges 2160:Japan
Address 2-2-2 Nihonbashi Honcho, 3rd Floor, Nihonbashi Honcho YS Building, Chuo-ku, Tokyo, JPN, 103-0023
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
82GF Score

Get the complete analysis for GNIIF

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.50
Price
$17.11
GF Value